https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: details id: 26917

News

OUHSC Research News - Monday, July 10, 2023


Published: Friday, July 7, 2023

 

Notices and Reminders

OCAST FY24 Applications: The only OCAST programs to have funding for award in FY2024 (July 1, 2023 – June 30, 2024) are the Oklahoma Applied Research Support (OARS) program and the Intern Partnership program.  The OCAST Health Research, Health Research Fellowship and Plant Science programs will go unfunded in FY2024.  Please note projects supporting industry in the three targeted strategic areas with the greatest probability of maximum return, Biotech/life sciences (including Ag-Tech), aerospace/autonomous systems and defense, and energy diversification are eligible for the OARS program.  The OARS program in FY2024 will not offer proof-of-concept funding. Applications are open August 2nd.

 

Workshops and Seminars

OK Symposium on Pancreatic Cancer Cachexia
OU Health Stephenson Cancer Center is proud to host the OK Symposium on Pancreatic Cancer Cachexia on August 25-26, 2023 at the Colcord Hotel in Oklahoma City.
The purpose of this symposium is to advance the understanding of the basis of pancreatic cancer cachexia and enhance research collaborations on pancreatic cancer. Pancreatic cancer and cancer cachexia are under-studied areas that have drawn much attention in the last few years. Funded by the Presbyterian Health Foundation and the NCI designated OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences Center, this multidisciplinary symposium will provide a unique opportunity to catalyze interactions among invited speakers and local investigators through sharing ideas, research discoveries, and challenges towards advancing the field of pancreatic cancer cachexia. The meeting will highlight speakers from many premier research institutions in the nation, and local speakers from several institutions within the state. The topics to be covered will feature cutting edge technologies, new animal models and novel discoveries on pancreatic cancer cachexia. Specifically: muscle wasting, adipose loss, cross talk between muscle and adipose and tumor cells, inflammation, metabolism, extracellular vesicles, microRNAs, cytokines, and pancreatic cancer metastasis.

Register: 2023 International Ovarian Cancer Research Conference Registration (qualtrics.com)  

Contact: Emily Hulseberg emily-hulseberg@ouhsc.edu

 

Omics for the Biomedical researcher workshop

This fall we are planning on having a workshop where we will teach biomedical researchers how to perform basic informatics analysis, with a particular focus on single cell RNA sequencing. In this hands-on workshop, we will teach participants how run raw data (in the form of FASTQ files) through Cellranger, upload the data into R, process the data, and generate usable visualizations including UMAPs, Heatmaps, and volcano plots. We will also teach researchers how to perform ligand-receptor and pseudotime analysis.  These analyses will be done using bash, linux, R, and python platforms. This workshop will take place over the course of ~four months and will require the participant to attend one, four-hour session per week (12 sessions total). The course will be held in person at the Samis Center, East Boardroom. No fee will be charged for the workshop. A description of the requirements and applications materials is listed below. We anticipate accepting 10 applicants into the workshop. Applications are due by July 15th, 2023. Please send application materials to Kurt Zimmerman (kurt-zimmerman@ouhsc.edu).

Please see attached document for more complete information and the schedule of classes.

 

OUHSC Funding Opportunities

Office of Technology Commercialization presents the following opportunity for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • EuroFarma, a Brazilian pharmaceutical company, is seeking antimicrobial small molecules from natural sources for drugs/therapies.  Of particular interest are small molecules, both natural products and their derivatives, that target gram-negative and ESKAPE pathogens or other pathogens related to antimicrobial resistance.  Approaches that target Candida, Aspergillus fumigatus, Gram positive bacteria and human cytomegalovirus, RSV and rhinovirus will also be considered.  Out of scope are nucleic acids and proteins, and non-molecular approaches such as probiotics or phytotherapeutic medicines. Submission entails a one-page 200-300 word non-confidential brief. (deadline 08/10).
  • A pharmaceutical company focused on women’s health is seeking novel druggable targets and drug candidates in the area of obstetrics and gynecology for in-licensing or early collaboration, including research project/PhD funding.  All mechanisms of action are of interest with examples being anti-fibrotic effect, ovulation failure, hormone replacement and osteoporosis. Open to different modalities with small molecule and peptides of highest interest.  Novel screening methods to identify targets and research related to novel contraceptives are also of interest.  Submission entails a one-page 200-300 word non-confidential brief. (deadline 08/19). 

NOTE: If the project is selected to move forward with a full application, it will need to be routed through SoonerTrack II.

 

NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

Oklahoma Center for Respiratory and Infectious Diseases (OCRID) Call for Proposals

2023-2024 Pilot Project Grants

Description: The purpose of the pilot project grant program is to provide seed funding to generate preliminary data for an extramural research grant application. Applicants must propose a project that fits into the central theme of the OCRID research areas, i.e., infectious diseases of the respiratory system and associated complications. Projects that use OCRID research cores (Animal Model Core, Immunopathology Core and Molecular Biology Core) are highly encouraged, as are projects that incorporate novel and advanced technologies, including, but not limited to, single-cell and spatial transcriptomics, cell-specific knockout/transgene, cell lineage tracing, machine learning/AI, organoids and stem cell technologies, human lung cell and tissue models, etc. OCRID also encourages applicants to consider the unique opportunities of having several Core-provided services in (A)BSL-3 settings. OCRID and its associated Cores will also provide infrastructure and research guidance to pilot project applicants and awardees as needed to help develop their projects.

Application deadline: August 1, 2023

Link to Full Announcement: Please refer to the attached flyer.

 

The Robert Wood Johnson Foundation’s (RWJF): Health Data for Action (Data Access Award)

Description: Access to rich data is a cornerstone of producing timely and objective research. Data can build evidence that leads to a fair and just opportunity for health, for all.  A new call for proposals offers no-cost access to timely, relevant, inclusive data that inform policy to make healthcare more affordable and equitable.  Health Data for Action will award successful applicants with access to data sets to support innovative research that answers important research questions and inform health policy. Data include electronic health record and clinical data; claims and encounter data; and transparency in coverage data. First-time principal investigators will receive funding up to $100,000 per project.

Applications Deadline: August 18, 2023

Link to Full Announcement: https://www.rwjf.org/en/grants/active-funding-opportunities/2023/health-data-for-action-data-access-award.html?rid=0032S00002ZyzqpQAB&et_cid=2196580

 

The International Center for Responsible Gaming (ICRG): Grant Support for Research on Responsible Gambling and Prevention of Gambling Disorder

Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for a grant to study responsible gambling and prevention strategies designed to reduce gambling-related harms. Although a variety of topics are welcome, the safety and efficacy of Voluntary Self-Exclusion is a priority. Applicants may request up to $60,000 per year in direct costs for up to three years plus 15 percent in Facilities & Administration costs. The ICRG will support one grant award under this initiative, which was made possible by support from GeoComply.

Application Deadline: October 16, 2023

Link to Full Announcement: https://www.icrg.org/information/apply-for-icrg-funding

Documents to download